Scandinavian Study Shows HPV Vaccination Safe

“In a large study of nearly a million girls in Denmark and Sweden, the human papillomavirus [HPV] vaccine was not linked to short- or long-term health problems,” Reuters reports. “Previously, isolated incidents of blood clots or other problems had been pegged to the vaccine, but this large new study did not find any negative health consequences, researchers said,” the news agency writes, noting the report is published in BMJ. “More than 100 million doses have been administered worldwide since the first HPV vaccine was approved in 2006,” Reuters adds (Doyle, 10/23).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.